KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Astrana Health (ASTH) over the last 16 years, with Q1 2025 value amounting to $8000.0.

  • Astrana Health's Change in Accured Expenses fell 9911.6% to $8000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$31.8 million, marking a year-over-year decrease of 70578.83%. This contributed to the annual value of -$30.9 million for FY2024, which is 1808764.71% down from last year.
  • As of Q1 2025, Astrana Health's Change in Accured Expenses stood at $8000.0, which was down 9911.6% from -$56.8 million recorded in Q4 2024.
  • Astrana Health's Change in Accured Expenses' 5-year high stood at $24.8 million during Q2 2024, with a 5-year trough of -$56.8 million in Q4 2024.
  • For the 5-year period, Astrana Health's Change in Accured Expenses averaged around -$1.6 million, with its median value being $905000.0 (2024).
  • Within the past 5 years, the most significant YoY rise in Astrana Health's Change in Accured Expenses was 139806.41% (2024), while the steepest drop was 608366.7% (2024).
  • Astrana Health's Change in Accured Expenses (Quarter) stood at -$11.1 million in 2021, then soared by 92.7% to -$814000.0 in 2022, then skyrocketed by 216.58% to $949000.0 in 2023, then tumbled by 6083.67% to -$56.8 million in 2024, then surged by 100.01% to $8000.0 in 2025.
  • Its Change in Accured Expenses stands at $8000.0 for Q1 2025, versus -$56.8 million for Q4 2024 and $198000.0 for Q3 2024.